NPCE Q2 2024 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$482M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+16.6% YoY

Gross Profit

$14M73.4% margin

Operating Income

-$6M-32.4% margin

Net Income

-$8M-39.0% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+6.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$94M

Total Liabilities

$85M

Stockholders' Equity

$10M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$17M	+16.6%
Gross Profit	$14M	$12M	+18.1%
Operating Income	-$6M	-$8M	+20.7%
Net Income	-$8M	-$9M	+17.6%